CAS NO: | 1977495-97-8 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Trilaciclib hydrochloride (G1T28 hydrochloride) is aCDK4/6inhibitor withIC50s of 1 nM and 4 nM forCDK4andCDK6, respectively[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Incubation with Trilaciclib hydrochloride (G1T28) for 24 hours induces a robust G1cell-cycle arrest (time=0). By 16 hours after Trilaciclib hydrochloride washout, cells have reentered the cell cycle and demonstrate cell-cycle kinetics similar to untreated control cells. These results demonstrate that Trilaciclib hydrochloride causes a transient, and reversible G1arrest. A transient Trilaciclib hydrochloride-mediated G1cell-cycle arrest in CDK4/6-sensitive cells decreases thein vitrotoxicity of a variety of commonly used cytotoxic chemotherapy agents associated with myelosuppression[1]. | ||||||||||||||||
体内研究 (In Vivo) | Trilaciclib hydrochloride (G1T28) treatment results in a robust and dose-dependent suppression of proliferation in HSPCs at 12 hours, with 5-ethynyl-2′-deoxyuridine (EdU) incorporation returning near baseline levels in a dose-dependent manner by 24 hours after administration. These data demonstrate that a single oral dose of Trilaciclib hydrochloride can produce reversible cell-cycle arrest in HSPCs in a dose-dependent mannerin vivo. Mice given 100 mg/kg Trilaciclib hydrochloride 30 minutes prior to etoposide treatment, exhibits only background levels of caspase-3/7 activity. These data demonstrate that Trilaciclib hydrochloride can protect the bone marrow from chemotherapy-induced apoptosisin vivo. The data demonstrate that treatment with Trilaciclib hydrochloride prior to 5-fluorouracil (5-FU) likely decreases 5-FU-induced damage by chemotherapy in HSPCs, thus accelerating blood count recovery after chemotherapy[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 519.47 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C24H32Cl2N8O | ||||||||||||||||
CAS 号 | 1977495-97-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 25.64 mg/mL(49.36 mM;ultrasonic and adjust pH to 2 with HCl) DMSO : 1.1 mg/mL(2.12 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |